Market Reports
The Microbiome Drug Landscape report: Promising clinical performance and signs of a maturing industry
Abstract Year 2020 has been a pivotal year for microbiome-focused drug companies. This year the industry saw the release of two much-anticipated Phase 3 studies, which showed positive results and set the stage for new […]